Mast Cell Tumors in Cats: Skin, Splenic, and GI Forms

Mast cell tumors are among the most common tumors diagnosed in cats, ranking as the most frequent splenic tumor, the second most common skin tumor, and the third most common intestinal tumor in the species.¹ Unlike in dogs, where mast cell tumors are overwhelmingly a skin problem, feline mast cell tumors show up in three distinct locations, and how a tumor behaves depends heavily on where it grows. That single fact shapes nearly every decision your veterinarian will make, from how aggressively to treat the tumor to what kind of survival time to expect.

Where Mast Cell Tumors Grow in Cats

Mast cells are immune cells found throughout the body, concentrated in skin, the lining of the gut, and organs like the spleen. When these cells turn cancerous, the tumor can arise in any of those locations. In cats, the three main forms are cutaneous (skin), splenic, and intestinal. Each behaves differently enough that veterinary oncologists treat them almost as separate diseases. A skin mast cell tumor on a cat’s head might be surgically cured and never come back, while a mast cell tumor in the intestine might already have spread to lymph nodes at the time of diagnosis. Treatment and prognosis vary dramatically with location and the tumor’s microscopic appearance.²

Which Cats Are Most Likely to Develop Mast Cell Tumors

Mast cell tumors tend to appear in older cats. A large UK-based study found the median age at diagnosis was 11 years, though cases ranged from kittens as young as 5 months to senior cats of 19 years.³ There is no clear sex or neuter-status predilection. Male and female cats, whether intact or spayed or neutered, develop these tumors at similar rates.

Breed does matter, though. The same UK study identified Siamese, Burmese, Russian Blue, and Ragdoll cats as more susceptible to cutaneous mast cell tumors.⁴ An earlier study of skin tumors in 340 cats found that Siamese cats had roughly three times more mast cell tumors than would be expected by chance.⁵ Young Siamese cats in particular can develop a distinctive pattern of multiple small skin mast cell tumors that, as we will see later, sometimes resolve on their own.

Skin Mast Cell Tumors

Cutaneous mast cell tumors are the form most cat owners encounter. They usually show up as firm, raised lumps or nodules on the head, neck, or trunk. Some are hairless; others just feel like a small bump under the fur. Because mast cells release histamine and other inflammatory chemicals, the area around the tumor can occasionally become red, swollen, or itchy. Some cats develop multiple skin nodules rather than a single mass.

The good news is that most feline skin mast cell tumors behave in a relatively benign fashion compared with their canine counterparts. Surgery alone often provides a cure when the tumor can be removed with clean margins. The key question, though, is the tumor’s grade. A grading system proposed specifically for cats classifies cutaneous mast cell tumors as high grade when they have more than five dividing cells per microscopic field plus at least two additional features such as large tumor size, irregular nuclear shapes, or prominent internal cell structures. In a study of 63 feline skin mast cell tumors, roughly a quarter met the criteria for high grade, and those cats had a median survival of about 349 days. The low-grade tumors fared far better: the median survival time was never reached during the study period, meaning most of those cats were still alive when the researchers stopped counting.⁶

Among all the microscopic features pathologists examine, how rapidly the tumor cells are dividing, known as the mitotic index, is consistently the strongest predictor of outcome.⁷ Having multiple skin nodules and a more disorganized-looking tumor under the microscope also point toward a worse prognosis. So when your vet sends a biopsy to the lab, the pathology report’s details about mitotic rate and grade are the most important numbers to discuss.

Splenic Mast Cell Tumors

Mast cell tumors of the spleen are the single most common splenic tumor in cats. They can be tricky to catch early because the signs are vague. A cat with a splenic mast cell tumor might vomit intermittently, lose weight, or simply seem “off.” One reported case involved a 6-year-old domestic shorthair with four months of on-and-off vomiting and poor appetite before the tumor was found; bloodwork showed anemia and mast cells circulating in the bloodstream, and imaging revealed a massively enlarged spleen.⁸ Another case presented similarly with vomiting and weight loss in an 8-year-old cat.⁹

Vomiting is especially common with splenic and visceral mast cell tumors because the degranulating mast cells flood the body with histamine. That histamine can trigger excess stomach acid production and gastrointestinal ulceration, which is why antihistamines and stomach-protectant medications often become part of the treatment plan even before the tumor itself is addressed.

Surgery to remove the spleen makes a significant difference. A multi-institutional study of 64 cats with splenic mast cell tumors found that cats who had a splenectomy lived considerably longer: a median tumor-specific survival of 856 days in the splenectomy group versus 342 days in cats that did not have surgery.¹⁰ Another study found that when the tumor was confined to the spleen without involvement of other organs, the median survival was around 807 days, compared with just 120 days when disease had spread beyond the spleen.¹¹ So catching a splenic mast cell tumor before it disseminates gives cats the best chance, and splenectomy is well tolerated in most cases.

Intestinal Mast Cell Tumors

Mast cell tumors in the gut carry a reputation for being the most aggressive form, and that reputation has historically discouraged treatment. But more recent data paints a more nuanced picture. In a study that tracked cats treated for gastrointestinal mast cell tumors, the overall median survival was 531 days. That is not the grim prognosis many textbooks suggest. About a quarter of the cats in that study ultimately died of an unrelated cause rather than the tumor itself.¹² The takeaway is that intestinal mast cell tumors have extremely variable behavior; some are aggressive, but others respond well to treatment and allow months or years of good-quality life.¹³

Spread to abdominal lymph nodes is relatively common at diagnosis. One imaging study found enlarged abdominal lymph nodes in nine of the cats examined, with metastatic disease confirmed in seven of those. However, ultrasound was poor at detecting metastasis in the liver and spleen, catching it in only one of four cats with confirmed liver involvement and zero of three cats with splenic metastasis.¹⁴ This means that staging intestinal mast cell tumors often requires tissue sampling beyond just an ultrasound to get the full picture.

How Mast Cell Tumors Are Diagnosed

For skin lumps, the process is straightforward. Your vet inserts a small needle into the mass and withdraws a few cells onto a glass slide. This procedure, called fine needle aspiration, is quick, usually requires no sedation, and often gives an answer on the spot. Mast cells have a distinctive appearance under the microscope: round cells packed with dark-staining granules. Because these granules are so characteristic, mast cell tumors are among the easiest tumors to identify on a simple aspirate.

For internal tumors, the path to diagnosis is more involved. Splenic tumors are sometimes found incidentally on imaging done for another reason. If the spleen looks abnormal on ultrasound or X-ray, a needle aspirate of the spleen can be performed under ultrasound guidance. Intestinal mast cell tumors often require endoscopic biopsy or surgical biopsy for confirmation, particularly if the tumor is deep within the intestinal wall.

After a mast cell tumor is identified, your vet will typically recommend staging to determine whether the tumor has spread. This includes bloodwork, abdominal ultrasound, and sometimes chest X-rays. For skin tumors, the vet may also aspirate nearby lymph nodes. As noted in the section on intestinal tumors, ultrasound has clear limitations for detecting spread to the liver and spleen, so additional sampling may be warranted depending on the clinical picture.

Treatment Options

Surgery

Surgical removal is the first-line treatment for all three forms when it is feasible. For solitary skin tumors, complete excision with adequate margins is frequently curative. For splenic tumors, splenectomy provides the survival benefit described above. For intestinal tumors, surgical resection of the affected segment of bowel may be combined with removal of nearby lymph nodes.

The challenge with surgery varies by location. A single skin nodule on the ear or forehead is generally straightforward. A tumor wrapped around a loop of intestine or nestled against major blood vessels is a different proposition entirely. And when tumors have already spread to multiple sites, surgery alone is unlikely to address all the disease.

Toceranib Phosphate

Toceranib, sold under the brand name Palladia, is a targeted drug originally developed for mast cell tumors in dogs. It works by blocking certain receptor proteins on the surface of tumor cells. Although it is not formally licensed for cats, veterinary oncologists have been using it off-label with encouraging results. A retrospective study of 50 cats with mast cell tumors treated with toceranib found clinical benefit in 80% of cases overall, including roughly 86% of cats with cutaneous tumors, 80% of those with visceral tumors, and 76% of those with gastrointestinal disease. The median duration of treatment for cats that responded ranged from about 23 weeks for gastrointestinal cases to 48 weeks for visceral cases.¹⁵

Side effects occurred in about 60% of cats treated, but the majority were mild gastrointestinal or blood-count changes that resolved with a treatment break or dose adjustment.¹⁶ Toceranib is often considered when surgery is not an option, when the tumor has come back after surgery, or when the disease has spread to multiple sites.

Supportive Medications

Because mast cells release histamine and other inflammatory compounds when they degranulate, supportive care plays a surprisingly important role. Antihistamines help control itching, redness, and swelling around the tumor. Stomach-acid reducers protect the gastrointestinal tract from histamine-driven acid overproduction and ulceration. If your cat is on treatment for a mast cell tumor, your vet will likely prescribe one or both of these alongside whatever primary therapy is being used.

Spontaneous Regression in Young Cats

One of the more unusual aspects of feline mast cell tumors is that some skin tumors regress entirely on their own. This has been documented primarily in young cats, especially young Siamese. In a study that followed cats with a particular subtype of cutaneous mast cell tumor, tumors underwent apparently spontaneous regression within two years of initial detection.¹⁷ These self-resolving tumors tend to be small, well-differentiated, and located in the skin rather than deeper tissues.

This does not mean you should adopt a wait-and-see approach for every skin lump on a young cat. Some tumors that appear harmless on the surface turn out to be high-grade under the microscope. But it does explain why your vet might suggest monitoring a tiny skin nodule in a young Siamese rather than immediately recommending surgery, provided a fine needle aspirate confirms the cells look well-differentiated and benign.

The KIT Mutation Question

If you have researched mast cell tumors in dogs, you have probably read about KIT mutations and how they can guide treatment decisions. In dogs, certain mutations in the KIT gene predict more aggressive behavior and better response to targeted drugs like toceranib. The situation in cats is murkier.

KIT mutations are common in feline mast cell tumors. One study of cutaneous tumors found mutations in 56% of cases, but those mutations were not significantly related to prognosis or to how the KIT protein was expressed on the cell surface.¹⁸ Even more confusingly, when the same cat had multiple skin tumors, different nodules could carry different mutations, meaning the mutation status changed from one lump to the next within the same animal.¹⁹

Research into the functional effects of specific KIT mutations in cats has added another layer of complexity. A study examining multiple KIT variants found within a single feline splenic mast cell tumor showed that different mutations had different effects on cell growth. One mutation promoted proliferation, another appeared to have no effect, and a third actually suppressed cell growth entirely.²⁰ The idea that a single tumor can harbor both growth-promoting and growth-suppressing mutations at the same time underscores why KIT testing in cats has not become the straightforward clinical tool it is in dogs. Veterinary oncologists are still working out which mutations matter and which are just background noise.

How Prognosis Differs Across All Three Forms

Pulling the survival data together gives a practical framework. Low-grade cutaneous tumors have the best outlook: most cats survive for years after surgical removal, and many are effectively cured. High-grade cutaneous tumors carry a median survival closer to a year.²¹ Splenic tumors treated with splenectomy can yield median survivals well over two years, especially when the disease is confined to the spleen.²² Intestinal tumors fall somewhere in between, with a median survival approaching a year and a half in treated cats, and a meaningful fraction of those cats ultimately dying of something other than the tumor.²³

These numbers should be interpreted carefully. Survival statistics come from groups of cats, and individual outcomes vary based on tumor grade, extent of disease at diagnosis, response to treatment, and the cat’s overall health. But the broad pattern is clear: the old assumption that any visceral mast cell tumor in a cat equals a death sentence does not hold up against the data. Aggressive treatment, particularly surgery when feasible and targeted therapy when needed, buys many cats meaningful time with a good quality of life.

What Mast Cell Tumors Look Like Day to Day

Living with a cat who has a mast cell tumor raises a set of practical concerns that survival statistics alone do not answer. Mast cell degranulation, where tumor cells dump their contents into the surrounding tissue or the bloodstream, can cause sudden flare-ups. You might notice a lump that was calm yesterday now looking swollen and red, or your cat might vomit unexpectedly even though they seemed fine in the morning. These episodes reflect histamine release and are typically manageable with the supportive medications your vet prescribes, but they can be alarming if you are not expecting them.

Cats with splenic or intestinal tumors may also develop anemia over time. Periodic blood tests help catch dropping red blood cell counts early so your vet can adjust the treatment plan. Weight loss and decreased appetite are common enough with visceral tumors that maintaining caloric intake sometimes becomes its own project, involving appetite stimulants or specially palatable foods.

If your cat is on toceranib, you will likely visit the vet every few weeks for blood counts and monitoring, at least initially. Most cats tolerate the drug well enough that the visit schedule becomes less frequent over time. Watching for signs of gastrointestinal upset, particularly diarrhea or poor appetite, and reporting them early makes a meaningful difference, since catching mild side effects allows the vet to adjust the dose before they become a bigger problem.